跳至主要内容
临床试验/ISRCTN11668233
ISRCTN11668233进行中(未招募)Unknown

A non-interventional, mixed-methods, prospective cohort study to characterise the real-world implementation, roll out, safety and patient experience of the long-acting injectable HIV treatment regimen of 2-monthly cabotegravir and rilpivirine

niversity of Sussex0 个研究点目标入组 200 人开始时间: 2024年2月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Understand the participant information and the study requirements and has the capacity to consent
  • 2. Willing to comply with study procedures
  • 3. Age 16 years or above
  • 4. Is a member of one of the following groups:
  • 4.1. LA group - PLWH who have been recently switched (within the prior 6 months) or are prospectively switched to LA CAB+RPV during the enrolment period. This includes those who have received LA CAB+RPV outside of BHIVA criteria or on compassionate grounds.
  • 4.2. Oral ART group - PLWH who are demographically similar but not eligible for LA CAB+RPV according to BHIVA eligibility criteria and who continue oral ART within the study period (e.g. those who are HBVcoreAb+ or who have an underlying drug resistance mutation that precludes use of LA CAB+RPV). The intervention group to the oral group will be matched 3:1 by calendar period and other key variables where possible.

排除标准

  • 1. In the opinion of the investigator is unable or unwilling to comply with the study requirements
  • 2. Aged < 16 years old

研究者

发起方
niversity of Sussex

相似试验

Cabotegravir and rilpivirine real-world experience | 临床试验